rLVS(delta) capB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli

By sjmartinez • May 27, 2025

Jia Q, Bowen RA, Masleša-Galić S, Horwitz MA. rLVS ΔcapB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli. Hum Vaccin Immunother. 2025 Dec;21(1):2507475. doi: 10.1080/21645515.2025.2507475. Epub 2025 May 26. PMID: 40417828.

Tags: bioterrorism, F1, Francisella tularensis, Infectious Diseases, LcrV, LVS ΔcapB, plague, Publications, single vector platform vaccine, Tier 1 select agent, vaccine, Yersinia pestis

Cefepime and Mortality-A Dosing Problem, Not a Drug Problem

Uslan DZ, Smith EA. Cefepime and Mortality-A Dosing Problem, Not a Drug Problem. JAMA Netw Open. 2026 Sep 1;9(9):e2632904. doi: 10.1001/jamanetworkopen.2026.32904. PMID: 42720957.

Immunotherapy for invasive Candida infections: Translating host-directed strategies into clinical practice

Sprute R, Singh S, Conti HR, Cornely OA, van de Veerdonk FL, Carvalho A, Ibrahim AS. Immunotherapy for invasive Candida infections: Translating host-directed strategies into[...]

Hypertension Prevalence and Control at Trial Entry in the REPRIEVE Study Population: Results From a Secondary Analysis

Hoffman R, Watanabe M, Martínez E, Zanni MV, Pozniak A, Shakil SS, McCallum S, Chu SM, Srinivasa S, Malvestutto CD, Fichtenbaum CJ, Bloomfield GS, Lu[...]